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Abstract
Short-chain fatty acids (SCFAs), especially butyrate, affect cell differentiation, proliferation, and motility. Butyrate also
induces cell cycle arrest and apoptosis through its inhibition of histone deacetylases (HDACs). In addition, butyrate is a
potent inducer of histone hyper-acetylation in cells. Therefore, this SCFA provides an excellent in vitro model for studying
the epigenomic regulation of gene expression induced by histone acetylation. In this study, we analyzed the differential in
vitro expression of genes induced by butyrate in bovine epithelial cells by using deep RNA-sequencing technology (RNA-
seq). The number of sequences read, ranging from 57,303,693 to 78,933,744, were generated per sample. Approximately
11,408 genes were significantly impacted by butyrate, with a false discovery rate (FDR) ,0.05. The predominant cellular
processes affected by butyrate included cell morphological changes, cell cycle arrest, and apoptosis. Our results provided
insight into the transcriptome alterations induced by butyrate, which will undoubtedly facilitate our understanding of the
molecular mechanisms underlying butyrate-induced epigenomic regulation in bovine cells.
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Introduction
Short-chain fatty acids (SCFAs), such as acetate, propionate,
and butyrate, are important nutrients in ruminants. SCFAs are
produced during the microbial fermentation of dietary fiber in the
gastrointestinal tract and are directly absorbed at the site of
production and oxidized for cell energy production and use [1]. In
humans, colonic microbiota convert dietary fiber into prodigious
amounts of SCFAs that benefit the human host through numerous
metabolic, trophic, and chemopreventative effects [2]. The SCFA
butyrate, in particular, also serves as an inhibitor of histone
deacetylases (HDACs), which are critical epigenetic regulators
[3,4,5]. Therefore, butyrate could act to reactivate epigenetically
silenced genes by increasing global histone acetylation [6].
Epigenetic modifications play a key role in the regulation of gene
expression, and HDAC activity contributes significantly to
epigenetic modification. The HDACs are part of a transcriptional
co-repressor complex that influences various tumor suppressor
genes. HDACs also play significant roles in several human cancers,
making HDAC inhibitors an important emerging class of
chemotherapeutic agents.
Chromatin modification has evidently evolved to be a very
important mechanism for the epigenetic regulation of the
transcriptional status of a genome [4]. Butyrate is not only
important for its nutritional impact. It also has profound impacts
at the gene level, altering cell differentiation, proliferation, and
motility and inducing cell cycle arrest and apoptosis [3]. The
foremost biochemical change induced by butyrate and other
HDAC inhibitors is the global hyper-acetylation of histones [3,7].
Clear evidence has linked modifications in chromatin structure to
cell cycle progression, DNA replication, and overall chromosome
stability [8,9]. Cultured bovine cells respond to the hyper-
acetylation of histones induced by butyrate at physiological
concentrations by arrest in the early G1 phase and the cessation
of DNA synthesis. Butyrate at a relatively high concentration also
induces apoptosis in an established bovine cell line, the Madin-
Darby bovine kidney epithelial cell line (MDBK) [3]. The
modulation of genome expression through chromatin structural
changes by processes such as histone acetylation is considered a
major genetic control mechanism.
Histone lysine acetylation has emerged as an essential regulator
of genome organization and function. As a HDAC inhibitor
(HDACi), butyrate is a strong inducer of the hyper-acetylation of
histone in cells and provides an excellent in vitro model for the
study of the epigenomic regulation of gene expression induced by
histone acetylation. An investigation of the global gene expression
profiles of MDBK cells and their regulation by sodium butyrate
has recently been conducted using a high-density oligonucleotide
microarray [10]. The profound changes observed in gene
expression in bovine cells following butyrate treatment demon-
strate the pleiotropic effects of histone acetylation [5]. As nutrition
research shifts from epidemiology and physiology to the study of
molecular interactions with the genome and the elucidation of
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changes in gene expression becomes necessary as a basis for
understanding these molecular mechanisms.
In the present study, we report our findings on the function and
pathways induced by butyrate in MDBK cells. We used deep
RNA sequencing to provide a significant amount of novel gene
information for bovine cell transcription, which can then be used
for further transcriptomic studies or to gain a deeper understand-
ing of the bovine genome and transcriptome. This study also
provides a significant amount of information for the epigenetic
regulation induced by butyrate. Our data show that butyrate-
induced histone acetylation results in subsequent changes in the
accessibility of the DNA to transcription activities. Transcriptomic
characterization using deep RNA sequencing facilitates the
identification of the potential mechanisms underlying gene
expression and the epigenomic regulation of cellular functions
induced by butyrate.
Results
Butyrate treatment induces changes in cell morphology
and cell cycle arrest
We previously reported that butyrate induces cell cycle arrest in
MDBK cells. In preparation for deep RNA sequencing, we first
endeavored to confirm that the butyrate induced cell cycle arrest.
When cells were treated with 10 mM butyrate for 24 hours, cell
morphology became distorted. Cells with large vacuoles, with
ragged membranes, lacking distinct intracellular organelles, and
having increased spaces between cells were readily visible and
recurrent. Flow cytometry analysis of the cell population profiles
for DNA content and BrdU labeling also confirmed that the cells
were arrested at the G1 and G1/S boundary. The incorporation
of the BrdU label suggested that DNA synthesis was blocked by
butyrate treatment. Western blotting also confirmed that butyrate
induced the hyper-acetylation of H3 (Figure 1).
RNA-seq provided a comprehensive view of the bovine
cell transcriptome
In total, 57,303,693 to 78,933,744 sequence reads were
generated per sample (Table 1), and 24,526 genes had at last
one sequence hit in at least one sample. Of these, 16,212 genes
were shared by all samples and can be considered to be the core
transcriptome of the bovine epithelial cell. A mean value of
19,4776155 (mean6SD) genes was detected in the butyrate-
treated group, while 17,6266125 (mean6SD) genes were detected
in the control group. Table 2 summarizes the alignment results.
Among these genes, 11,408 genes showed a significant differential
expressed at a strict false discovery rate (FDR) ,0.05 (Table S1).
Previous gene expression profiling in MDBK cells and the
induction of histone acetylation by butyrate has been analyzed by
using bovine oligonucleotide microarray. In this previous study, 30
genes representing different expression levels and functional classes
were selected and validated by real-time RT-PCR [5]. We were
able to confirm over 70% of the differentially regulated genes that
were identified by the microarray experiment using RNA-seq.
However, RNA-seq allowed us to identify a significantly greater
numbers of genes that were induced by butyrate, but which had
not been previously associated with the biological effects of
butyrate. Transcriptome characterization by RNA-seq also
identified 587 genes that were uniquely expressed in butyrate-
treated cells, but had not been previously detected by a microarray
experiment in cells given similar treatments [5].
Functional annotation of differentially expressed genes
induced by butyrate
The biological relevance of butyrate-induced gene expression in
bovine cells was explored by the Gene Ontology (GO) classifica-
tion. Table 3 lists 65 GO terms that were significantly perturbed
by butyrate treatment. The most-represented biological processes
and molecular functions, sorted by statistical significance in both
terms of p–value and FDR, included nucleic acid metabolic
process, DNA metabolic processes, the regulation of the cell cycle,
and DNA replication.
Global function and pathway analyses identified the
mechanism of butyrate-induced cell cycle arrest
The functional category and pathway analysis of differentially
expressed genes in cells treated with butyrate were explored using
the IPA (Ingenuity Pathways Analysis, IngenuityH Systems, www.
ingenuity.com) Knowledge Base. Of the 24,525 genes in the data
set, 13,885 genes were mapped, and 10,637 genes were not
mapped in the database. These genes were uploaded for IPA.
Among the 13,885 mapped genes, 8,862 genes were identified
with matched gene symbols and were used in pathway analysis. Of
these, 5,542 genes were significantly up-regulated, while 3,320
genes were significantly down-regulated by butyrate. In compar-
ison, the earlier microarray reports [10] identified only 371 genes
(285 genes down- and 86 up-regulated genes) for the IPA analysis.
Functional analysis identified the biological functions and/or
diseases that were most significantly enriched in the dataset. When
the functional category analysis of the genes was performed, genes
from the datasets that were associated with biological functions
and/or diseases in the Ingenuity Pathways Knowledge Base were
considered for analysis. Fischer’s exact test was used to calculate
the P values. The top five molecular and cellular functions, as
determined by P-value, are listed in Table 4. These five functional
categories may represent the mechanisms underlying the essential
biological effects of butyrate treatment, including cell morphology
changes, cell cycle arrest, and apoptosis. The number of genes
defined in each function category was greatly extended by RNA-
seq to include 2,257 genes involved in cell death and 2,322 genes
involved in cellular growth and proliferation (Table 4).
We illustrated the functional changes induced by butyrate
treatment by separately comparing the functional categories that
were up- or down-regulated. Figure 2 shows the top fifteen
functional categories that were significantly enriched in either up-
or down-regulated genes. Cell cycle; DNA replication, recombi-
nation, and repair; and RNA post-transcriptional modification
were among the functional categories that were significantly
impaired by butyrate. In contrast, cell death, cellular growth and
proliferation, molecular transport, and cellular signaling categories
were enhanced by butyrate.
Four canonical pathways (Cell cycle G2/M DNA damage
checkpoints, purine metabolism, pyrimidine metabolism, and G1/
S checkpoint regulation) previously identified by the microarray
experiment were also confirmed by the RNA-seq analysis. In
addition, many other pathways were significantly impacted by
butyrate treatment, including those directly related to cell cycle
regulation, DNA replication, and cell cycle control of chromo-
somal replication; these finding were consistent with the observed
phenotypic changes in cell cycle arrest and the blockage of DNA
synthesis induced by butyrate. Signaling pathways, including NF-
kB, IGF-1, p53, TGF-b, and apoptosis signaling, were also
significantly induced by butyrate (Figure 3 and Table S2).
Butyrate-Induced Epigenomic Regulation
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to cell cycle progression
IPA analysis identified 1,117 genes associated with cell cycle
progression that were differentially regulated by butyrate (p-value:
up to 5.86E
228) (Table 4). These genes were involved in various
checkpoint pathways and selected examples of these pathways
were analyzed in further detail. A complete list of pathways is
presented in the supplementary material (Table S3).
Regulation of the cell cycle: The G1/S checkpoint control is
vital for normal cell division. Deregulation of the expression of
checkpoint proteins can lead to apoptosis or tumorigenesis. This
pathway highlights the key components of G1/S checkpoint
regulation. Our data indicated that the G1/S checkpoint
regulation pathway is one of the significantly down-regulated
Figure 1. Butyrate induces significant biological effects in cultured MDBK cells. a): normal cells; b): cells treated with10 mM butyrate for
24 hrs, showing morphological changes including large vacuoles, ragged membranes, lack of distinct intracellular organelles, and increasing spaces
between cells. Insert in a) comparison of histone H3 acetylation of normal cells (1) and histone acetylation in butyrate-treated cells (2). c and d: Cell
population profiles determined by flow cytometry. c); normal cells and d) cells treated with butyrate. Inserts: BrdU labeling show butyrate blocked the
DNA synthesis after 24 hr treatment. Cells were first pulse labeled with BrdU for 30 min. Collected cells were first stained with diluted fluorescent
(Fluorescent isothiocyanate, FITC) anti-BrdU antibody and then stained with DNA marker (7-ADD). The fluorescent signal generated by FITC was
acquired in a logarithmic mode, and fluorescent signal from the DNA-content marker 7-ADD was normally acquired in the linear signal amplification
mode. Cells were separated into three clusters by double staining analysis. Butyrate treatment eliminates cells in S phase (in rectangle box).
doi:10.1371/journal.pone.0036940.g001
Table 1. Summary of RNA-Seq coverage data.
Sample ID Yield (Mbases) # Reads
% of raw clusters
per lane
% Perfect
Index Reads
% One Mismatch
Reads (Index)
%o f.=Q30
Bases (PF)
Mean Quality
Score (PF)
BT1 3,371 67,423,659 39.48 85.92 14.08 89.37 35.44
BT2 3,365 67,298,291 39.98 80.36 19.64 89.23 35.42
BT3 2,865 57,303,693 33.57 81.88 18.12 89.45 35.43
BT4 3,947 78,933,744 44.68 88.33 11.67 89.56 35.54
C1 3,918 78,367,052 36.59 92.6 7.4 90.83 35.87
C2 2,910 58,207,130 43.22 92.63 7.37 87.2 34.75
C3 3,551 71,026,638 43.7 60.27 39.73 88.46 35.12
C4 3,083 61,656,681 47.79 95.99 4.01 87.17 34.83
BT; butyrate treated; C: Control.
doi:10.1371/journal.pone.0036940.t001
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ATM, ATR, BTRC, CCND1, CCND2, CCND3, CCNE1,
CCNE2, CDC25A, CDK2, CDK4, CDK6, CDKN1A,
CDKN1B, CDKN2B, E2F1, E2F2, E2F3, E2F4, E2F6, GSK3B,
HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6,
HDAC7, HDAC9, HDAC10, HDAC11, MAX, MYC, PA2G4,
RB1, RBL1, RBL2, SIN3A, SKP2, SMAD3, SUV39H1, TFDP1,
TGFB2, TGFB3, TP53) were deregulated by butyrate treatment.
Among the 46 genes, 27 were down-regulated (Figure 4). It is very
interesting to note that HDACs were among these deregulated
genes; for example, HCACs 1, 4, 7, 9, and 10 were down-
regulated, while HDACs 2, 3, 5, 6, and 11 were significantly up-
regulated by butyrate.
Regulation of DNA replication: cell cycle control of chromo-
somal replication is another canonical pathway closely related to
cell cycle progression. The top functions of these pathways
included DNA replication, recombination, and repair; cell cycle
regulation; cellular assembly; and cellular organization. The stable
propagation of genetic information requires that the entire
genome of an organism be faithfully replicated only once in each
cell cycle. Therefore, chromosomal DNA replication in eukaryotic
cells entails a series of complex events that includes the recognition
of origins, the firing of replication origins, the loading of DNA
polymerases onto the origins, and the elongation of newly
synthesized DNA. The initiation of DNA replication takes place
only at specific loci on the chromosomal DNA, which are termed
replication origins. The Origin Recognition Complex (ORC)
includes six components (ORC1 to ORC6), which are specifically
associated with replication origin throughout the cell cycle. ORC
serves as a hallmark of the origins and is highly conserved. ORC1
is the largest subunit of the origin recognition complex and the
association of ORC1 with chromatin appears to be the rate-
limiting step in the assembly of a functional pre-replication
complex [11]. Our data revealed that 23 genes from a total of 30
genes involved in this pathway were regulated by butyrate. These
genes (such as CDC45, CDC6, CDC7, CDK, CDT1, CHEK2,
DBF4, DNA Polymerase, MCM, ORC, ORC-CDC45-CDT1-
MCM-RPA, ORC1, ORC2, ORC3, ORC4, ORC5, ORC6,
which are the important components for the formation of the pre-
replication complex, as well as RC and RPA) were all significantly
down-regulated (Figure 5).
The canonical pathway of cell cycle regulation by BTG proteins
may also play an important role in butyrate-induced cell cycle
arrest. As shown in Figure 6, both BTG1 and BTG2 were up-
regulated by butyrate treatment. BTG1 expression reaches a
maximum in the G0/G1 phases of the cell cycle and then begins to
undergo down-regulation as cells progress through G1. BTG1
negatively regulates cell proliferation [12]. BTG2 proteins are
anti-proliferation proteins involved in cell cycle regulation, growth
arrest, and differentiation. The activation of BTGs may lead to the
down-regulation of the cyclin E/CDK2 complex and other
members of the cyclin family that are essential for the progression
of the cell cycle from G1 to the S phase and that are responsible
for the regulation of cyclin-dependent kinases. All of these
differentially expressed genes and their functions are in agreement
with our results and with the observed biological effects of
butyrate.
Our data also demonstrated that cytokinesis was significantly
down-regulated, with a p-value of 5.22E
209and a Z-score of
22.781 (Table 5). A total of 48 genes in this pathway were down-
regulated, including Aurora kinases A, B and C. The KIF (kinesin
superfamily of microtubule-associated motors) members, such as
KIF 4A, C1, 20A, 23, were also significantly down-regulated (from
24.0 to 27.6 fold). These findings confirm the earlier microarray
results that showed that butyrate induced changes in the
expression of genes related to cytokinesis [5].
Transcription factors: Transcription factors are a group of
proteins that bind to specific DNA sequences and control the
transcription of genetic information from DNA to mRNA [13].
Transcription factors either promote (as activators) or block (as
repressors) the recruitment of RNA polymerase to specific genes.
Table 6 lists the major transcription factors identified by RNA-seq
and IPA analysis that were involved in the regulatory effect of
butyrate. Only the genes with a predicted activation state, either
activated or inhibited, are listed.
TP53, one of the most important transcription factors, was
found in the center of a down-regulated network in the microarray
profiling of butyrate-induced regulation. However, microarrays
failed to detect changes in TP53 gene expression. In the present
experiment with RNA-seq, TP53 was clearly down-regulated by
butyrate (,4 fold). TP53 targets 518 genes in the entire dataset of
differentially expressed genes induced by butyrate (Table S4). In
addition to TP53, butyrate also induced the expression of
TP53BP1, TP53BP2, TP53I13, TP53INP1 (tumor protein p53
inducible nuclear protein 1), and TP53I11. TP53INP1 was up-
regulated (2.5 fold), while functionally-associated gene TP73 was
up-regulated almost 24-fold. All of these changes in gene
expression suggest a cell-cycle regulation network that may
enhance cell cycle arrest.
The expression of non-coding RNAs (ncRNA) was disrupted by
butyrate treatment: Deep RNA-seq also reveals a significant
amount of information regarding ncRNA. There are 24 ncRNAs
that are differentially expressed due to the butyrate treatment.
Those ncRNAs belong to different types of ncRNAs, including
snoRNA (small nucleolar RNA), snRNA (splicesomal RNA), and
some miscRNAs (Table 7). Particularly, the expression of 10
snoRNAs (5 down-regulated and 5 up-regulated) was found to be
disrupted by the butyrate treatment. snoRNAs are intermediate-
sized ncRNAs (60–300 bp). They are components of small
nucleolar ribonucleoproteins (snoRNPs), which are complexes
that are responsible for the modification and processing of
ribosomal RNA [14]. More importantly, a large proportion of
snoRNAs have been found to be further processed into smaller
molecules, such as microRNAs (miRNAs) [15]. Surprisingly, only
one miRNA with differential expression was detected. We suspect
that the RNA purification protocols may exclude small RNAs. It is
certainly interesting to follow-up this finding to look into the
functionality of the disruption of the expression of ncRNA induced
by butyrate.
Table 2. Summary of the bovine transcriptome in MDBK cells
(Genes with at least one hit).
Sample replicate
Butyrate
-treated Control
1 19207 17804
2 19248 17523
3 19282 17615
4 19550 17560
Mean 19477 17626
SD 155 125
P-value =0.0000026
doi:10.1371/journal.pone.0036940.t002
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GO ID Description Ratio in Study Ratio in Population p-value FDR
GO:0090304 Nucleic acid metabolic process 1226/11408 1618/16591 5.87E-10 0.000
GO:0036094 Small molecule binding 1489/11408 1973/16591 5.89E-10 0.000
GO:0034641 Cellular nitrogen compound metabolic process 1798/11408 2400/16591 6.68E-10 0.000
GO:0006139 Nucleobase-containing compound metabolic process 1612/11408 2146/16591 6.71E-10 0.000
GO:0006807 Nitrogen compound metabolic process 1837/11408 2469/16591 6.76E-10 0.000
GO:0044260 Cellular macromolecule metabolic process 2593/11408 3496/16591 7.02E-10 0.000
GO:0000166 Nucleotide binding 1402/11408 1862/16591 7.02E-10 0.000
GO:0044446 Intracellular organelle part 2447/11408 3252/16591 7.03E-10 0.000
GO:0005634 Nucleus 2303/11408 3089/16591 7.32E-10 0.000
GO:0044444 Cytoplasmic part 2764/11408 3742/16591 7.45E-10 0.000
GO:0005737 Cytoplasm 2097/11408 2778/16591 7.64E-10 0.000
GO:0044237 Cellular metabolic process 3632/11408 4917/16591 7.89E-10 0.000
GO:0044422 Organelle part 2482/11408 3308/16591 7.92E-10 0.000
GO:0043170 Macromolecule metabolic process 2859/11408 3905/16591 8.05E-10 0.000
GO:0044238 Primary metabolic process 3647/11408 4986/16591 8.21E-10 0.000
GO:0003674 Molecular_function 8856/11408 12490/16591 8.32E-10 0.000
GO:0043227 Membrane-bounded organelle 3833/11408 5154/16591 8.34E-10 0.000
GO:0043229 Intracellular organelle 4370/11408 5881/16591 8.78E-10 0.000
GO:0044464 Cell part 7397/11408 10297/16591 8.81E-10 0.000
GO:0003824 Catalytic activity 3290/11408 4535/16591 8.82E-10 0.000
GO:0043226 Organelle 4376/11408 5887/16591 8.85E-10 0.000
GO:0005575 Cellular_component 7714/11408 10774/16591 8.89E-10 0.000
GO:0005515 Protein binding 5263/11408 7294/16591 8.94E-10 0.000
GO:0008150 Biological_process 7442/11408 10453/16591 9.01E-10 0.000
GO:0043231 Intracellular membrane-bounded organelle 3828/11408 5149/16591 9.26E-10 0.000
GO:0005488 Binding 7434/11408 10421/16591 9.39E-10 0.000
GO:0008152 Metabolic process 4284/11408 5856/16591 9.42E-10 0.000
GO:0009987 Cellular process 5831/11408 8120/16591 9.53E-10 0.000
GO:0044424 Intracellular part 5586/11408 7576/16591 1.02E-09 0.000
GO:0044428 Nuclear part 1045/11408 1375/16591 1.14E-09 0.000
GO:0050789 Regulation of biological process 3605/11408 5012/16591 6.52E-09 0.000
GO:0065007 Biological regulation 3746/11408 5215/16591 6.90E-09 0.000
GO:0043234 Protein complex 1507/11408 2030/16591 9.92E-09 0.000
GO:0006259 DNA metabolic process 341/11408 423/16591 3.66E-08 0.000
GO:0035639 Purine ribonucleoside triphosphate binding 1153/11408 1540/16591 3.96E-08 0.000
GO:0032555 Purine ribonucleotide binding 1160/11408 1551/16591 5.16E-08 0.000
GO:0032553 Ribonucleotide binding 1160/11408 1551/16591 5.16E-08 0.000
GO:0050794 Regulation of cellular process 3389/11408 4718/16591 6.51E-08 0.000
GO:0017076 Purine nucleotide binding 1162/11408 1556/16591 8.73E-08 0.000
GO:0048518 Positive regulation of biological process 1395/11408 1885/16591 1.27E-07 0.000
GO:0031090 Organelle membrane 656/11408 855/16591 1.59E-07 0.000
GO:0009058 Biosynthetic process 1443/11408 1954/16591 1.72E-07 0.000
GO:0044249 Cellular biosynthetic process 1379/11408 1864/16591 1.95E-07 0.000
GO:0048523 Negative regulation of cellular process 1136/11408 1525/16591 2.79E-07 0.000
GO:0048522 Positive regulation of cellular process 1262/11408 1704/16591 4.98E-07 0.000
GO:0048519 Negative regulation of biological process 1222/11408 1649/16591 6.09E-07 0.000
GO:0033554 Cellular response to stress 384/11408 488/16591 8.35E-07 0.000
GO:0080090 Regulation of primary metabolic process 1874/11408 2574/16591 1.17E-06 0.002
GO:0005730 Nucleolus 269/11408 334/16591 1.20E-06 0.002
GO:0051726 Regulation of cell cycle 301/11408 377/16591 1.21E-06 0.002
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During the last few years, several publications have reported the
use of HDAC inhibitors to study histone acetylation and gene
regulation. An important question to be addressed by the study of
histone modification is how modifications affect not only
chromatin dynamics but also various processes (e.g., DNA
replication, RNA transcription) along the DNA-template. These
processes can be influenced by a number of post-translational
modifications of histones, including acetylation, methylation,
phosphorylation, and ubiquitination. These modifications may
not act alone, but in concert and in a context-dependent manner
to facilitate or repress chromatin-mediated processes [6].
Our previous studies [3,5,10,16] revealed that VFAs, especially
butyrate, participate in metabolism, both as nutrients and as
regulators of histone modification, thereby regulating the ‘epige-
nomic code.’ These findings implicate histone modifications
induced by butyrate as determinants of bovine phenotype and in
bovine ruminal development.
Epigenomics is an emerging area of scientific investigation that
is confirming the complexity of the mechanisms used to determine
the how, when, and where of gene expression in order to ensure
the normal development, health, and homeostasis of the animal.
The recently completed profiling of global gene expression used a
high-density oligonucleotide microarray [5,10] to identify 450
genes in bovine kidney epithelial cells that were significantly
regulated by sodium butyrate at a very stringent false discovery
rate (FDR) of 0%. The functional category and pathway analyses
of the microarray data revealed that four canonical pathways (cell
cycles: G2/M DNA damage checkpoint, pyrimidine metabolism,
G1/S checkpoint regulation, and purine metabolism) were
significantly perturbed. The biologically relevant networks and
pathways of these genes were also identified, including genes such
as IGF2, TGFB1, TP53, E2F4, and CDC2, which were established
as central to these networks. However, because they are restricted
to probes designed to target the genes in a given species’ genome,
hybridization-based microarray technologies offer a limited ability
to fully catalogue and quantify the diverse RNA molecules that are
expressed from genomes over a wide range of levels [17], and they
often fail to capture the full catalogue of transcripts and their
variations.
The development of the next-generation sequencing (NGS) has
provided novel tools for expression profiling and genome analysis
[17,18,19]. As a vital step towards a comprehensive understanding
of the molecular mechanism of butyrate-induced acetylation, as
well as its biological effects, the present study was designed to
utilize next-generation sequencing technology in order to provide
a more complete characterization of the RNA transcripts of
MDBK cells. This study also focused on the comparison between
the control group (without butyrate treatment) and the cells
Table 3. Cont.
GO ID Description Ratio in Study Ratio in Population p-value FDR
GO:0051236 Establishment of RNA localization 51/11408 53/16591 1.53E-06 0.002
GO:0050658 RNA transport 51/11408 53/16591 1.53E-06 0.002
GO:0050657 Nucleic acid transport 51/11408 53/16591 1.53E-06 0.002
GO:0006950 Response to stress 689/11408 909/16591 1.65E-06 0.002
GO:0005524 ATP binding 913/11408 1222/16591 2.36E-06 0.002
GO:0032559 Adenyl ribonucleotide binding 917/11408 1228/16591 2.49E-06 0.002
GO:0005815 Microtubule organizing center 229/11408 282/16591 2.65E-06 0.002
GO:0005813 Centrosome 197/11408 240/16591 3.14E-06 0.002
GO:0051028 mRNA transport 42/11408 43/16591 3.16E-06 0.002
GO:0031323 Regulation of cellular metabolic process 1886/11408 2597/16591 3.19E-06 0.002
GO:0015931 Nucleobase-containing compound transport 58/11408 62/16591 3.20E-06 0.002
GO:0019222 Regulation of metabolic process 2104/11408 2907/16591 3.30E-06 0.002
GO:0006260 DNA replication 89/11408 100/16591 3.52E-06 0.002
GO:0031570 DNA integrity checkpoint 48/11408 50/16591 3.82E-06 0.003
GO:0030554 Adenyl nucleotide binding 919/11408 1233/16591 4.15E-06 0.003
doi:10.1371/journal.pone.0036940.t003
Table 4. Summary of top molecular and cellular function
regulated by butyrate.
Function Annotation p-Value
Number of
Genes
Cell Death 7.27E-49 2257
Gene Expression 9.41E-48 1544
Cellular Growth and Proliferation 4.88E-39 1420
Cellular Assembly and Organization 1.49E-28 1164
Cellular Function and Maintenance 1.49E-28 1565
Cell Cycle 5.86E-28 1117
Molecular Transport 1.54E-24 1320
Post-Translational Modification 4.02E-23 1074
Cellular Movement 9.17E-21 1318
Cellular Development 2.76E-19 1701
Cell Signaling 3.69E-16 692
Carbohydrate Metabolism 1.01E-14 572
DNA Replication, Recombination, and
Repair
1.71E-14 718
Cellular Compromise 4.21E-14 145
doi:10.1371/journal.pone.0036940.t004
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e36940Figure 3. Global Canonical Pathway analysis: Comparison of three datasets (up-, down-regulated gene datasets, and a combined
dataset. Datasets were analyzed by the Ingenuity Pathways Analysis software (IngenuityH Systems, www.ingenuity.com). The significance is
expressed as a p-value, which is calculated using the right-tailed Fisher’s Exact Test.
doi:10.1371/journal.pone.0036940.g003
Figure 2. Global functional analysis. Comparison of three datasets (up-, down-regulated gene datasets and combined dataset. Datasets were
analyzed by the Ingenuity Pathways Analysis software (IngenuityH Systems, www.ingenuity.com). The significance value associated with a function in
Global Analysis is a measure for how likely it is that genes from the dataset file under investigation participate in that function. The significance is
expressed as a p-value, which is calculated using the right-tailed Fisher’s Exact Test.
doi:10.1371/journal.pone.0036940.g002
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replicates (four lanes for controls and four lanes for butyrate-
treated samples), the samples were deep-sequenced, with an
average of more than 67 million reads per sample, and the results
were used to estimate the differences induced by butyrate
treatment. Therefore, our results show a very reliable and detailed
profiling of the changes in gene expression induced by butyrate.
This study has generated comprehensive information on an
experimental system that can be used in many functional genomics
studies of bovine cells. To the best of our knowledge, this is the first
study that has used NGS and IPA to identify the influences of
butyrate on transcriptomic characterization in a normal bovine
cell line. IPA analysis revealed that butyrate exerts a very broad
range of effects on many biological pathways through its inhibitory
action on HDACs in the MDBK cell line. Our NGS results, with a
comparative transcriptomic profiling approach, extended far
beyond the findings reported using microarray technologies
[10,20]. The phenomenal number of genes we identified that fall
within a broad range of functional categories appear to provide a
very detailed molecular basis for the butyrate-induced biological
effects.
The stable propagation of genetic information requires that the
entire genome of an organism be faithfully replicated only once in
each cell cycle. In eukaryotes, this replication is initiated at
hundreds to thousands of replication origins distributed over the
genome, each of which must be prohibited from re-initiating DNA
replication within a single cell cycle [21]. Initiation of DNA
replication is a two-step process: First, initiation proteins are
assembled onto the replication origin in a stepwise fashion to
develop a pre-replication complex. Second, the initiation complex
is activated by protein kinases, resulting in the establishment of
replication forks. This process is tightly regulated, such that
initiation at a given replication origin occurs only once per cell
cycle. In addition, initiation is down-regulated in response to
agents that damage DNA or block DNA replication.
In eukaryotic cells, cell cycle checkpoint regulation assures the
fidelity of cell division. The G1 (first gap phase)/S cell cycle
checkpoint controls the passage of eukaryotic cells from the G1
into the S phase. Mitogen-dependent progression through the G1
of the cell-division cycle is accurately regulated to ensure that
normal cell division is synchronous with cell growth and that the
initiation of DNA synthesis (the S phase) is timed precisely to avoid
inappropriate DNA amplification. The G1/S checkpoint control is
vital for normal cell division and involves the key components that
include cell cycle kinases, CDK4/6-cyclin D and CDK2-cyclin E,
and the transcription complex composed of the retinoblastoma
protein (Rb) and transcription factor E2F. The activation of E2F is
necessary for the G1-S transition. In the present report, CDK4/6
Figure 4. The biologically relevant pathways: Regulation of the cell cycle: The G1/S checkpoint control. The dataset was analyzed by
the Ingenuity Pathways Analysis software (IngenuityH Systems, www.ingenuity.com). The color indicates the expression level of the genes (red
indicating up-regulated genes and green indicating down-regulated genes).
doi:10.1371/journal.pone.0036940.g004
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butyrate-induced histone acetylation. In contrast, p21, a cell cycle
inhibitor protein, was significantly up-regulated. All of these
perturbations of gene expression in the G1/S cell cycle checkpoint
pathways are consistent with the observed biological effects of
butyrate, which induces cell cycle arrest at the G1/S boundary [3].
Butyrate is able to inhibit all class I HDACs. It also seems to
affect many other epigenetic-related enzymes by regulating the
expression of genes. The missing link is why this inhibition of
enzymatic activities, in turn, regulates their own expression at the
mRNA level. In this report, we found a vastly complicated
depiction of the expression of HDACs induced by butyrate
treatment. Whereas the expression of HCACs 7, 8, and 9 are
down-regulated, HDACs 5 and 11 are up-regulated, and HDACs
1, 2, 4, and 6 are unchanged (Table S1). HDAC inhibitors that
affect the expression of the HDACs themselves have been
observed in mouse neural cells [22]. In that report, both TSA
and SB indeed elevated the expression of HADC1, HDAC3,
HDAC5, and HDAC6, whereas the mRNA levels for HDAC 2
and HDAC7 did not change. The mRNA levels of HDAC8 and
HDAC10 were not detectable in these cells. The mechanism and
biological relevance of HDAC inhibitors in the regulation of the
expression of HDACs is not clear, but may possibly indicate the
existence of an auto-regulatory feedback loop for the expression of
several HDACs after their activities are inhibited.
Butyrate, as a histone deacetylase inhibitor, can also decrease
histone methylation [23], suggesting an interplay between histone
acetylation and histone methylation. An emerging possibility is
that histone modifications can influence one another. In other
words, there may be ‘‘crosstalk among histone modification’’ [24].
Figure 5. The biological relevant pathways: Cell Cycle Control of Chromosomal Replication. Data set was analyzed by the Ingenuity
Pathways Analysis software (IngenuityH Systems, www.ingenuity.com). The color indicates the expression level of the genes (red indicating up-
regulated genes and green indicating down-regulated genes).
doi:10.1371/journal.pone.0036940.g005
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trimethyl-K4), was significantly up-regulated by butyrate treat-
ment (Table S1). However, JSRID2, which is directly related to
histone methylation and responsible for maintaining the methyl-
ation level on histone H3 lysine 27 trimethylation (H3K27me3)
[25], was also significantly up-regulated. JARID2 possesses an in
vitro methyl-protective activity, stabilizing Polycom Repressive
Complex 2 (PRC2)-catalyzed H3K27me3 by protecting it from
the activity of H3K27 demathylases [26]. These data may indicate
that different histone marks (modifications) are differentially
regulated and that in turn, differentially regulated histone marks
regulate different biological functions [27]. On the other side, a
reversal of DNA methylation by butyrate has also recently been
reported to occur by the regulation of DNA (cytosine-5-)-
methyltransferase 1 (DNMT1) through ERK signaling [28]. In
this report, we found that three DNA methyltransferases
(DNMTs), DNMT1, DNMT3A, and DNMT3B, were significant-
ly down-regulated by the butyrate treatment (Table S1). While
DNMT1 functions in the establishment and regulation of tissue-
specific patterns of methylated cytosine residues, DNMT3A and
DNMT3B function in the de novo methylation of DNA [29,30].
These DNMTs are regulated by several mechanisms in terms of
their expression and catalytic activity. However, for the first time,
our data directly indicated that histone modification has a role in
the regulation of the expression of DNMTs, thereby affecting the
level of DNA methylation.
The first clear evidence that a six-subunit ‘‘origin recognition
complex’s’’ (ORC) activity in mammalian cells is regulated by cell
cycle–dependent changes in the affinity of the largest subunit
(Orc1) for chromatin has been reported [11,21]. Evidence has
since confirmed these findings and extended them to show that
mammalian Orc1 is selectively ubiquitinated and phosphorylated
during the S-to-M–phase transition, while ORC subunits 2 to 5,
which constitute a stable core complex, remain tightly bound to
chromatin throughout cell division [31]. In addition, a second
mechanism prevents the assembly of a functional ORC until the
completion of mitosis: the selective association of Orc1 with Cdk1
(Cdc2)/cyclin A during the G2/M phase of cell division. This
association accounted for the appearance in M-phase cells with
hyperphosphorylated Orc1 that was subsequently dephosphory-
lated during the M-to-G1 transition [32]. The rebinding of Orc1
to chromatin follows the same time course as the degradation of
Figure 6. The biological relevant pathways: Cell cycle regulation by BTG proteins. The dataset was analyzed by the Ingenuity Pathways
Analysis software (IngenuityH Systems, www.ingenuity.com). The color indicates the expression level of the genes (red indicating up-regulated genes
and green indicating down-regulated genes).
doi:10.1371/journal.pone.0036940.g006
Table 5. Butyrate down-regulated the major functions involved in cell cycle regulation.
Functions Annotation p-Value Predicted Activation State Regulation z-score Number of genes
Cell Cycle 4.73E-28– 9.26E-05 Decreased 1117
Cell cycle progression 4.73E-28 0.190 718
Interphase 1.86E-25 Decreased 22.439 484
G1 phase 1.71E-15 Decreased 22.524 278
Cytokinesis 5.22E-09 Decreased 22.781 90
Interphase of fibroblasts 4.26E-06 Decreased 22.615 48
Interphase of connective
tissue cells
4.99E-06 Decreased 22.474 52
doi:10.1371/journal.pone.0036940.t005
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binding to chromatin. In fact, the inhibition of Cdk activity in
metaphase cells resulted in the rapid binding of Orc1 to
chromatin, and NGS profiling shows that all six subunits of
ORC are down-regulated by butyrate-induced histone acetylation,
adding yet another layer of regulation of ORC activities via the
modified expression of those genes. In our previous microarray
profiling [10], some of the components of this pathway were found
to be perturbed by butyrate-induced gene regulation; however,
ORC1 was the only one of the six ORC complex genes that was
detected to be a down-regulated gene. In the present report,
ORC1 is still the most significantly down-regulated gene, but the
other ORC components (ORC2 to ORC6) are all also identified
as down-regulated. This result certainly indicates the superb
sensitivity of deep RNA sequencing.
We also found significant up-regulation of both BTG1 and
BTG2. The BTG family member-2 (BTG2) has antiproliferative
activity, and the expression of BTG2 in cycling cells induces the
accumulation of hypophosphorylated, growth-inhibitory forms of
retinoblastoma protein (Rb) and leads to G1 arrest through the
impairment of DNA synthesis. These up-regulated antiprolifera-
tion activities are strengthened by the extensive repression of
cyclin-dependent kinase and cell cycle-related genes that are
clearly associated with the cell growth arrest induced by butyrate.
Tumor protein p53 (TP53, a nuclear protein), transcription
factor E2F4, and many other transcription factors, were deregu-
lated by butyrate treatment in the present study. TP53 plays an
Table 6. Major transcription regulators with defined activities regulated by butyrate treatment.
Transcription Regulator Predicted Activation State Regulation z-score p-value of overlap
TP53 Activated 3.288 2.91E-28
KDM5B Activated 3.232 3.43E-05
IRF3 Activated 3.145 1.57E-01
Creb Activated 2.794 1.71E-02
MXI1 Activated 2.693 2.03E-02
OTX2 Activated 2.678 2.08E-01
EZH2 Activated 2.557 3.59E-01
IRF1 Activated 2.500 3.60E-03
NR3C2 Activated 2.482 7.11E-02
ELF4 Activated 2.427 1.32E-01
CBX4 Activated 2.383 2.43E-01
MYOG Activated 2.291 1.07E-01
MSX2 Activated 2.211 7.31E-02
HTT Activated 2.168 2.01E-04
CEBPA Activated 2.166 9.32E-07
Rb Activated 2.158 1.88E-03
POU4F1 Activated 2.065 5.82E-03
JUNB Activated 2.047 1.72E-01
NR3C1 Activated 2.024 2.71E-17
STAT5A Activated 2.023 1.47E-03
N-cor Inhibited 22.071 3.50E-01
MEF2A Inhibited 22.086 3.74E-01
SP3 Inhibited 22.311 2.38E-03
Ctbp Inhibited 22.368 2.03E-02
KAT5 Inhibited 22.442 6.45E-02
IRF9 Inhibited 22.447 3.83E-01
HSF2 Inhibited 22.481 8.28E-02
E2F3 Inhibited 22.492 4.99E-04
Hdac Inhibited 22.789 1.77E-02
FOXM1 Inhibited 23.064 4.61E-03
SREBF2 Inhibited 23.150 4.67E-02
FLI1 Inhibited 23.592 1.92E-02
MYC Inhibited 23.759 1.15E-11
SIRT2 Inhibited 23.987 7.01E-03
XBP1 Inhibited 24.077 6.15E-11
HSF1 Inhibited 24.744 2.03E-03
doi:10.1371/journal.pone.0036940.t006
Butyrate-Induced Epigenomic Regulation
PLoS ONE | www.plosone.org 11 May 2012 | Volume 7 | Issue 5 | e36940essential role in the regulation of the cell cycle, specifically in the
transition from G0 to G1. It is found in very low levels in normal
cells; however, in a variety of transformed cell lines, it is expressed
in high amounts and is believed to contribute to transformation
and malignancy. P53 is a DNA-binding protein that contains
DNA-binding, oligomerization, and transcription activation do-
mains. P53 is postulated to bind as a tetramer to a p53-binding site
and activate the expression of downstream genes that inhibit
growth and/or invasion, thereby functioning as a tumor suppres-
sor.
P53 has been extensively studied for its function and involve-
ment in butyrate-induced biological effects [33,34,35]. Butyrate
efficiently suppresses the growth of WT p53-containing cells. It
leads to a major G2/M arrest of cells in the presence of p53, while
cells without wild-type p53 accumulate mainly in the G1 phase of
the cell cycle. Apoptosis induction by butyrate is also greatly
reduced in the absence of p53, suggesting that a p53 pathway
mediates, in part, growth suppression by butyrate and that p53
status may be an important determinant of chemosensitivity to
butyrate [36]. Our data also indicate that the TP53 genes may
have different responses and different roles to play in normal and
transformed cells. In our dataset, 518 genes were potential targets
for TP53 regulation. Among these 518 genes, 238 genes showed
expression directions consistent with the activation of TP53.
However, one remaining question is why the expression of TP53
was down-regulated, even as its function was more active. As an
extremely regulated gene, two major factors may contribute to this
complexity of TP53. First, the expression of TP53 is subject to
multiple regulations at transcriptional, post-transcriptional, and
translational levels, with very complex expression patterns of
alternative splicing, alternative promoter usage, and alternative
translation. Secondly, the regulation of p53 function is extremely
complex and occurs at many levels. Post-translational modifica-
tions of p53 (phosphorylation, methylation, acetylation, etc.) alter
the functions of p53 (recognition of DNA sequences, interactions
with transcription factors at promoters of target genes, etc.) [37].
Indeed, deep RNA-seq and IPA analysis revealed significant
changes in the expression of genes related to the molecular
function of protein post-translational modification (Figure 2).
There are 333 genes related to the phosphorylation of proteins, 80
genes related to the tyrosine phosphorylation of proteins, and 106
genes related to the activation of protein kinase, which is up-
regulated by butyrate. The possibility exists that the modification
of p53 is affected by butyrate, directly or indirectly. Clearly, more
Table 7. Butyrate-induced disruption in non-coding RNA expression.
ENSEMBL_ID Gene Biotype Fold (BT/CT) Description locus p_value q_value
ENSBTAG00000044614 snoRNA 0.18 Small Cajal body specific
RNA 23
6:109784641–109826922 1.01E-02 0.0153
ENSBTAG00000045102 snoRNA 0.34 Small nucleolar RNA
U89
5:103853321–103857548 1.07E-04 0.0002
ENSBTAG00000042757 snoRNA 0.38 Small nucleolar RNA
SNORA20
9:97466404–97492748 1.56E-08 0.0000
ENSBTAG00000043000 snoRNA 0.38 Small nucleolar RNA
SNORA1
29:1066221–1066355 1.83E-02 0.0270
ENSBTAG00000042183 snoRNA 0.41 Small nucleolar RNA
SNORA20
4:59551832–59551962 8.26E-05 0.0002
ENSBTAG00000047875 miRNA 0.67 Novel 19:49330953–49337523 2.79E-02 0.0402
ENSBTAG00000044453 misc_RNA 1.52 7SK RNA 4:113212666–113212975 1.28E-02 0.0192
ENSBTAG00000045419 misc_RNA 1.53 7SK RNA 6:27777684–27778005 1.31E-05 0.0000
ENSBTAG00000044427 misc_RNA 1.59 Nuclear RNase P 10:26814255–26814588 3.24E-02 0.0464
ENSBTAG00000043171 misc_RNA 1.68 7SK RNA 8:18781961–18782266 1.32E-04 0.0002
ENSBTAG00000045128 misc_RNA 1.68 7SK RNA 1:14608518–14608853 2.94E-02 0.0422
ENSBTAG00000045530 snoRNA 1.73 Novel 3:34395250–34395683 3.15E-03 0.0051
ENSBTAG00000043250 misc_RNA 1.79 7SK RNA 23:24977641–24977972 3.92E-03 0.0063
ENSBTAG00000046888 misc_RNA 2.06 Novel 6:31669691–31669966 2.77E-03 0.0045
ENSBTAG00000047075 misc_RNA 2.06 Novel 19:58435867–58436204 2.78E-02 0.0401
ENSBTAG00000044659 snoRNA 2.25 Small Cajal body specific
RNA 13
21:61984641–61984915 3.23E-02 0.0462
ENSBTAG00000046063 snoRNA 3.05 Novel 19:47441443–47441573 1.39E-02 0.0208
ENSBTAG00000042354 snoRNA 3.13 SNORA3/SNORA45 family 15:44469326–44472127 1.40E-02 0.0209
ENSBTAG00000048120 misc_RNA 3.80 Novel 3:34060768–34060962 1.08E-03 0.0018
ENSBTAG00000029640 snRNA 4.65 U1 spliceosomal RNA 18:14877691–14877845 2.71E-02 0.0391
ENSBTAG00000037013 snRNA 5.80 U1 spliceosomal RNA 21:45387108–45387272 2.23E-02 0.0325
ENSBTAG00000043738 misc_RNA 6.68 7SK RNA 15:43689412–43689680 2.43E-02 0.0353
ENSBTAG00000046209 snRNA 18.19 Novel 17:20132500–20132665 1.18E-03 0.0020
ENSBTAG00000042191 snoRNA .1000 Small nucleolar RNA U2-19 13:81838598–81838678 2.81E-02 0.0404876*
*No detectable in control samples.
doi:10.1371/journal.pone.0036940.t007
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plays in butyrate-induced biological effects.
In conclusion, the acetylation of histone tails is essential for
diverse cellular processes, such as DNA replication and cell cycle
progression. Butyrate-induced histone hyper-acetylation, however,
has some divergent activities, including the induction of cell cycle
arrest, gene expression, and apoptosis [3,10]. The transcriptome
characterization of bovine cells using RNAseq identified tran-
scriptional control mechanisms via butyrate. Our results extended
our knowledge of the regulatory effects of butyrate on gene
expression and will undoubtedly provide insight into the molecular
mechanisms of in vivo butyrate-induced epigenomic regulation.
Materials and Methods
Cell culture and butyrate treatment
Madin-Darby bovine kidney epithelial cells (MDBK, American
Type Culture Collection, Manassas, VA., and Catalog No. CCL-
22) were cultured in Eagle’s minimal essential medium and
supplemented with 5% fetal bovine serum (Invitrogen, Carlsbad,
CA) in 25 cm
2 flasks, as described in our previous report [3]. At
approximately 50% confluence, during the exponential phase, the
cells were treated for 24 hours with 10 mM sodium butyrate
(Calbiochem, San Diego, CA). A butyrate concentration of
10 mM was selected as it represents a physiologically relevant
dose and has previously been successfully used to evoke desired
changes in cell cycle dynamics [3]. Four replicate flasks of cells for
both treatment and control groups (i.e., a total of 8 samples) were
used for the RNA-seq experiments.
RNA extraction and sequencing using RNA-seq
Total RNA was extracted using Trizol (Invitrogen, Carlsbad,
CA, USA) followed by DNase digestion and Qiagen RNeasy
column purification (Qiagen, Valencia, CA, USA), as previously
described [5]. The RNA integrity was verified using an Agilent
Bioanalyzer 2100 (Agilent, Palo Alto, CA, USA). High-quality
RNA (RNA Integrity number or RIN .9.0) was processed using
an Illumina TruSeq RNA sample prep kit following the
manufacturer’s instruction (Illumina, San Diego, CA, USA). After
quality control procedures, individual RNA-seq libraries were then
pooled based on their respective 6-bp adaptors and sequenced at
50 bp/sequence, read using an Illumina HiSeq 2000 sequencer, as
described previously [38]. Approximately 67.5 million reads per
sample (mean 6 sd =67,527,11168,330,388.6) were generated.
Data analysis and bioinformatics
Raw sequence reads were first checked using our quality control
pipeline. Nucleotides of each raw read were scanned for low
quality and trimmed using SolexaQA [39]. Trimmed reads were
aligned to the bovine reference genome (Btau 4.0) using TopHat
[40]. Each SAM output file per sample from TopHat alignment,
along with the GTF file from ENSEMBL bovine genebuild v65.0,
were used in the Cuffdiff program in the Cufflink package (v1.3.0)
as input files [41] to test for differential expression. Mapped reads
were normalized based on the upper-quartile normalization
method and Cuffdiff modeled the variance in fragment counts
across replicates using the negative binomial distribution as
described previously [42].
Differentially-expressed genes in the transcriptome were further
analyzed using Gene Ontology (GO) analysis (GOseq) [43].
Enrichment of certain GO terms was determined based on
Fisher’s exact test. A multiple correction control (permutation to
control false discovery rate) was implemented to set up the
threshold to obtain the lists of significantly over-represented GO
terms.
The molecular processes, molecular functions, and genetic
networks following butyrate treatment were further evaluated by
analyzing differentially expressed genes using Ingenuity Pathways
Analysis (IPA, IngenuityH Systems, and www.ingenuity.com). IPA
is a software application that enables biologists to identify the
biological mechanisms, pathways and functions most relevant to
their experimental datasets or genes of interest [44,45,46,47,48].
Canonical pathway analysis of data sets
Analysis of canonical pathways identified the pathways from the
IPA library of canonical pathways that were most significant to the
data set. Genes from the data set that were associated with a
canonical pathway in the Ingenuity Pathways Knowledge Base
were considered for the analysis. The significance of the
association between the data set and the canonical pathway was
measured in two ways: 1) a ratio of the number of genes from the
data set that map to the pathway divided by the total number of
genes that map to the canonical pathway was displayed. 2)
Fischer’s exact test was used to calculate a p-value determining the
probability that the association between the genes in the dataset
and the canonical pathway was explained by chance alone.
Functional analysis of data sets
The Functional Analysis identified the biological functions and/
or diseases that were most significant to the data set. Genes from
the datasets that were associated with biological functions and/or
diseases in the Ingenuity Pathways Knowledge Base were
considered for the analysis. Fischer’s exact test was used to
calculate a p-value determining the probability that each biological
function and/or disease assigned to that data set was due to
chance alone.
Pathways analysis and network generation
A data set containing gene identifiers and corresponding
expression values was uploaded into in the application. Each gene
identifier was mapped to its corresponding gene object in the
Ingenuity Pathways Knowledge Base. These genes, called Focus
Genes, were overlaid onto a global molecular network developed
from information contained in the Ingenuity Pathways Knowledge
Base. Networks of these Focus Genes were then algorithmically
generated based on their connectivity.
Functional analysis of a network
The Functional Analysis of a network identified the biological
functions and/or diseases that were most significant to the genes in
the network. The network genes associated with biological
functions and/or diseases in the Ingenuity Pathways Knowledge
Base were considered for the analysis. Fischer’s exact test was used
to calculate a p-value determining the probability that each
biological function and/or disease assigned to that network was
due to chance alone.
Network/pathways graphical representation
A network pathway is a graphical representation of the
molecular relationships between genes/gene products. Genes or
gene products were represented as nodes, and the biological
relationship between two nodes were represented as an edge (line).
All edges were supported by at least 1 reference from the
literature, from a textbook, or from canonical information stored
in the Ingenuity Pathways Knowledge Base. The intensity of the
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regulation.
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